VFA
BHC icon

Valeo Financial Advisors’s Bausch Health BHC Stock Holding History

Valeo Financial Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$3K – 657
2021
Q1 		$3K Hold
100
– – ﹤0.01% 1680
2020
Q4 		$2K Sell
100
-2,000
-95% -$37.3K ﹤0.01% 1500
2020
Q3 		$33K Sell
2,100
-30
-1% -$517 ﹤0.01% 779
2020
Q2 		$39K Buy
2,130
+30
+1% +$529 ﹤0.01% 812
2020
Q1 		$38K Buy
2,100
+1,819
+647% +$43.9K ﹤0.01% 687
2019
Q4 		$8K Sell
281
-4,550
-94% -$118K ﹤0.01% 1158
2019
Q3 		$106K Hold
4,831
– – 0.01% 419
2019
Q2 		$122K Buy
4,831
+1,400
+41% +$33.2K 0.01% 391
2019
Q1 		$85K Buy
3,431
+3,250
+1,796% +$77.6K 0.01% 438
2018
Q4 		$3K Sell
181
-150
-45% -$3.57K ﹤0.01% 1189
2018
Q3 		$8K Buy
331
+150
+83% +$3.44K ﹤0.01% 1025
2018
Q2 		$4K Sell
181
-310
-63% -$6.41K ﹤0.01% 1179
2018
Q1 		$8K Hold
491
– – ﹤0.01% 980
2017
Q4 		$10K Sell
491
-100
-17% -$1.59K ﹤0.01% 827
2017
Q3 		$8K Buy
+591
New +$8.94K ﹤0.01% 744

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Valeo Financial Advisors's BHC Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 100 shares — an estimated $3K sold.

Valeo Financial Advisors first reported a position in BHC in Q3 2017 and held it in 15 quarters. The position peaked at $122K in Q2 2019. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 100 Bausch Health shares in Q2 2021, an estimated $3K.
  • Valeo Financial Advisors first reported a position in Bausch Health in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's Bausch Health position peaked at $122K in Q2 2019.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.